EUVIMEDEUVIMED entdecken
Crossref

The HDAC2/KAT2A-Lamin A lactylation axis regulates tumor progression and chemoresistance in bladder cancer

Guanghui Xu, Wei Zhao, Yuqin Li, Shuting Fang, Zhigang Wu, Minghao Zheng, Yongming Deng, Xi Zheng, Hongqian Guo, Wenli Diao, Junlong Zhuang

Cancer Letters · 2027-01 · 664 · 218968

DOI: 10.1016/j.canlet.2026.218968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2027-01. Verfasst von Guanghui Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210008, China; Insti…. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysine lactylation (Kla) is a post-translational modification implicated in tumor metabolic reprogramming, yet its functional significance in bladder cancer remains largely unexplored. Here, we identify lactylation of Lamin A in bladder cancer and elucidate its regulatory mechanisms in cisplatin resistance. Integrated lactylome and proteome profiling combined with mass spectrometry reveal that Lamin A is lactylated at K233 and K417, which are significantly elevated in bladder cancer tissues. Functional characterization demonstrates that lactylation of Lamin A suppresses tumor proliferation, inhibits migration, induces G1 cell cycle arrest, promotes apoptosis, and thus enhances cisplatin sensitivity, whereas lactylation-deficient mutants abrogate these effects, with K233 and K417 as the critical functional residues. Mechanistically, Lamin A delactylation enhances the binding between MRE11 and ATM, promotes the recruitment of MRE11 to DSB sites and activates the downstream CHK1/CHK2 signaling pathway, thereby promoting DNA repair and conferring cisplatin resistance. We further identify HDAC2 and KAT2A as the delactylase and lactyltransferase of Lamin A, respectively, with HDAC2 driving malignant phenotypes through K233 and K417 delactylation. Pharmacological inhibition of HDAC2 with entinostat effectively suppresses xenograft tumor growth in vivo in a Lamin A lactylation-dependent manner. Collectively, our findings define Lamin A lactylation as a tumor-suppressive modification and uncover the HDAC2/KAT2A-Lamin A axis as a critical factor of cisplatin response, suggesting that targeting this pathway may represent a promising therapeutic strategy for bladder cancer.

Schlagwörter

Stichwörter der Autor:innen

Bladder cancerCisplatinDNA damage repairHDAC2LactylationLamin A

Autor:innen und Institutionen

  • Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210008, China; Institute of Urology, Nanjing University, Nanjing, Jiangsu, 210008, China.
  • Department of Clinical Biochemistry, School of Laboratory Medicine, Chengdu Medical College, Chengdu, Sichuan, 610050, China; Clinical Laboratory, Clinical Medical College and the First Affiliated Hospital of Chengdu Me…
  • Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, China.
  • Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210008, China; Institute of Urology, Nanjing University, Nanjing, Jiangsu, 210008, China.…
  • Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210008, China; Institute of Urology, Nanjing University, Nanjing, Jiangsu, 210008, China;…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, G., Zhao, W., Li, Y., Fang, S., Wu, Z., Zheng, M., Deng, Y., Zheng, X., Guo, H., Diao, W., & Zhuang, J. (2027). The HDAC2/KAT2A-Lamin A lactylation axis regulates tumor progression and chemoresistance in bladder cancer. Cancer Letters, 664, 218968. https://doi.org/10.1016/j.canlet.2026.218968

Vancouver

Xu G, Zhao W, Li Y, Fang S, Wu Z, Zheng M, et al. The HDAC2/KAT2A-Lamin A lactylation axis regulates tumor progression and chemoresistance in bladder cancer. Cancer Letters. 2027;664:218968. doi:10.1016/j.canlet.2026.218968

BibTeX
@article{Xu2027,
  author = {Xu, Guanghui and Zhao, Wei and Li, Yuqin and Fang, Shuting and Wu, Zhigang and Zheng, Minghao and Deng, Yongming and Zheng, Xi and Guo, Hongqian and Diao, Wenli and Zhuang, Junlong},
  title = {The HDAC2/KAT2A-Lamin A lactylation axis regulates tumor progression and chemoresistance in bladder cancer},
  journal = {Cancer Letters},
  year = {2027},
  volume = {664},
  pages = {218968},
  doi = {10.1016/j.canlet.2026.218968}
}
Kostenlos starten →